Mylan (United States)

Mylan (United States)

Mylan N.V. was a global generic and specialty pharmaceuticals company. In November 2020, Mylan merged with Upjohn, Pfizer's off-patent medicine division, to form Viatris. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Mylan (United States), United States, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

53%


Total
Publications

3.5K


Total Open
Publications

1.8K


Total
Citations

130K


Open Access
Percentage

53%


Total
Publications

3.5K


Total Open
Publications

1.8K


Total
Citations

130K

Wikipedia

Website

download

Breakdown

19% 21% 12% 48%

Publisher Open

19%

Both

21%

Other Platform Open

12%

Closed

48%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

020406080100120140160180200220240260280Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

40%OA Journal

OA Journal 40%

543

Hybrid 28%

370

No Guarantees 32%

429

Other Platform Open

Institution 73%

830

Domain 25%

289

Other Internet 13%

144

Preprint 5%

53

Public 2%

25

Other Platform Locations

Name

Platform Type

Publications

University of Milan
Institution
349
PubMed Central
Domain
290
University of Castilla-La Mancha
Institution
155
DOI
Other Internet
131
University of Milano-Bicocca
Institution
82
European Organization for Nuclear Research
Institution
69
University of Modena and Reggio Emilia
Institution
36
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
34
Office of Scientific and Technical Information
Institution
26
arXiv
Preprint
26
1 / 13

Data updated 18 August 2025

Share

Share

Share